...vitamin B12 receptor and is in preclinical testing for cancer. Further details were not disclosed. Kyto Biopharma Inc....

...develop humanized MAbs targeting vitamin B12 receptor to treat cancer. Financial terms were not disclosed. Kyto Biopharma Inc....

...Prior, Kyto had development and marketing rights to resulting antibodies (see BioCentury, Jan. 29, 2001). Kyto Biopharma Inc....